nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SHBG—seminiferous tubule of testis—germ cell cancer	0.045	0.106	CbGeAlD
Levonorgestrel—AR—scrotum—germ cell cancer	0.0416	0.0982	CbGeAlD
Levonorgestrel—CYP19A1—seminiferous tubule of testis—germ cell cancer	0.0365	0.0862	CbGeAlD
Levonorgestrel—AR—seminiferous tubule of testis—germ cell cancer	0.0323	0.0763	CbGeAlD
Levonorgestrel—SRD5A1—eye—germ cell cancer	0.0138	0.0325	CbGeAlD
Levonorgestrel—SRD5A1—telencephalon—germ cell cancer	0.0126	0.0296	CbGeAlD
Levonorgestrel—PGR—Nuclear Receptors—NR0B1—germ cell cancer	0.0108	0.0801	CbGpPWpGaD
Levonorgestrel—SRD5A1—gonad—germ cell cancer	0.0105	0.0247	CbGeAlD
Levonorgestrel—PGR—Ovarian Infertility Genes—INHA—germ cell cancer	0.00917	0.0677	CbGpPWpGaD
Levonorgestrel—SRD5A1—adrenal gland—germ cell cancer	0.00913	0.0216	CbGeAlD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00857	0.0633	CbGpPWpGaD
Levonorgestrel—PGR—blood vessel—germ cell cancer	0.00849	0.02	CbGeAlD
Levonorgestrel—AR—Nuclear Receptors—NR0B1—germ cell cancer	0.00826	0.061	CbGpPWpGaD
Levonorgestrel—SRD5A1—endocrine gland—germ cell cancer	0.00792	0.0187	CbGeAlD
Levonorgestrel—SRD5A1—head—germ cell cancer	0.00782	0.0185	CbGeAlD
Levonorgestrel—SRD5A1—testis—germ cell cancer	0.00755	0.0178	CbGeAlD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00715	0.0528	CbGpPWpGaD
Levonorgestrel—CYP3A4—urine—germ cell cancer	0.00684	0.0161	CbGeAlD
Levonorgestrel—SHBG—neck—germ cell cancer	0.00674	0.0159	CbGeAlD
Levonorgestrel—ESR1—blood vessel—germ cell cancer	0.00664	0.0157	CbGeAlD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00653	0.0482	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—NR0B1—germ cell cancer	0.00636	0.047	CbGpPWpGaD
Levonorgestrel—AR—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00633	0.0467	CbGpPWpGaD
Levonorgestrel—CYP19A1—Ovarian Infertility Genes—INHA—germ cell cancer	0.00601	0.0444	CbGpPWpGaD
Levonorgestrel—SRD5A1—brain—germ cell cancer	0.00566	0.0134	CbGeAlD
Levonorgestrel—SHBG—brainstem—germ cell cancer	0.00515	0.0122	CbGeAlD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00503	0.0371	CbGpPWpGaD
Levonorgestrel—ESR1—neck—germ cell cancer	0.00475	0.0112	CbGeAlD
Levonorgestrel—CYP19A1—Metapathway biotransformation—NAT9—germ cell cancer	0.00456	0.0337	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00419	0.031	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.00412	0.0304	CbGpPWpGaD
Levonorgestrel—ESR1—embryo—germ cell cancer	0.00396	0.00935	CbGeAlD
Levonorgestrel—PGR—decidua—germ cell cancer	0.0039	0.00922	CbGeAlD
Levonorgestrel—SHBG—gonad—germ cell cancer	0.00381	0.00901	CbGeAlD
Levonorgestrel—SHBG—uterus—germ cell cancer	0.00379	0.00895	CbGeAlD
Levonorgestrel—SHBG—pituitary gland—germ cell cancer	0.00372	0.00879	CbGeAlD
Levonorgestrel—ESR1—brainstem—germ cell cancer	0.00363	0.00857	CbGeAlD
Levonorgestrel—PGR—uterus—germ cell cancer	0.00341	0.00806	CbGeAlD
Levonorgestrel—PGR—pituitary gland—germ cell cancer	0.00335	0.00792	CbGeAlD
Levonorgestrel—SHBG—adrenal gland—germ cell cancer	0.00332	0.00785	CbGeAlD
Levonorgestrel—AR—telencephalon—germ cell cancer	0.00328	0.00775	CbGeAlD
Levonorgestrel—ESR1—telencephalon—germ cell cancer	0.00322	0.00761	CbGeAlD
Levonorgestrel—SHBG—bone marrow—germ cell cancer	0.00322	0.0076	CbGeAlD
Levonorgestrel—AR—skin of body—germ cell cancer	0.00313	0.00739	CbGeAlD
Levonorgestrel—AR—decidua—germ cell cancer	0.00311	0.00734	CbGeAlD
Levonorgestrel—SHBG—female gonad—germ cell cancer	0.0031	0.00732	CbGeAlD
Levonorgestrel—CYP19A1—gonad—germ cell cancer	0.00309	0.0073	CbGeAlD
Levonorgestrel—CYP19A1—uterus—germ cell cancer	0.00307	0.00726	CbGeAlD
Levonorgestrel—ESR1—decidua—germ cell cancer	0.00305	0.00721	CbGeAlD
Levonorgestrel—PGR—adrenal gland—germ cell cancer	0.003	0.00707	CbGeAlD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.00299	0.0221	CbGpPWpGaD
Levonorgestrel—SHBG—endocrine gland—germ cell cancer	0.00288	0.00681	CbGeAlD
Levonorgestrel—PGR—female gonad—germ cell cancer	0.00279	0.0066	CbGeAlD
Levonorgestrel—SHBG—testis—germ cell cancer	0.00275	0.00649	CbGeAlD
Levonorgestrel—AR—gonad—germ cell cancer	0.00274	0.00647	CbGeAlD
Levonorgestrel—AR—uterus—germ cell cancer	0.00272	0.00642	CbGeAlD
Levonorgestrel—CYP19A1—adrenal gland—germ cell cancer	0.0027	0.00637	CbGeAlD
Levonorgestrel—ESR1—gonad—germ cell cancer	0.00269	0.00635	CbGeAlD
Levonorgestrel—AR—pituitary gland—germ cell cancer	0.00267	0.00631	CbGeAlD
Levonorgestrel—ESR1—uterus—germ cell cancer	0.00267	0.00631	CbGeAlD
Levonorgestrel—ESR1—pituitary gland—germ cell cancer	0.00262	0.00619	CbGeAlD
Levonorgestrel—PGR—endocrine gland—germ cell cancer	0.0026	0.00613	CbGeAlD
Levonorgestrel—SHBG—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.00259	0.0191	CbGpPWpGaD
Levonorgestrel—PGR—head—germ cell cancer	0.00256	0.00606	CbGeAlD
Levonorgestrel—SHBG—cerebellum—germ cell cancer	0.00254	0.006	CbGeAlD
Levonorgestrel—CYP19A1—female gonad—germ cell cancer	0.00251	0.00594	CbGeAlD
Levonorgestrel—PGR—testis—germ cell cancer	0.00248	0.00585	CbGeAlD
Levonorgestrel—Progesterone—SLC22A3—germ cell cancer	0.0024	0.514	CrCbGaD
Levonorgestrel—AR—adrenal gland—germ cell cancer	0.00239	0.00564	CbGeAlD
Levonorgestrel—ESR1—adrenal gland—germ cell cancer	0.00234	0.00553	CbGeAlD
Levonorgestrel—CYP19A1—endocrine gland—germ cell cancer	0.00234	0.00552	CbGeAlD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00231	0.0171	CbGpPWpGaD
Levonorgestrel—CYP19A1—head—germ cell cancer	0.00231	0.00545	CbGeAlD
Levonorgestrel—AR—spinal cord—germ cell cancer	0.0023	0.00543	CbGeAlD
Levonorgestrel—PGR—cerebellum—germ cell cancer	0.00229	0.0054	CbGeAlD
Levonorgestrel—Testosterone—SLC22A3—germ cell cancer	0.00227	0.486	CrCbGaD
Levonorgestrel—CYP19A1—testis—germ cell cancer	0.00223	0.00526	CbGeAlD
Levonorgestrel—AR—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00223	0.0164	CbGpPWpGaD
Levonorgestrel—AR—female gonad—germ cell cancer	0.00222	0.00525	CbGeAlD
Levonorgestrel—ESR1—female gonad—germ cell cancer	0.00218	0.00516	CbGeAlD
Levonorgestrel—AR—endocrine gland—germ cell cancer	0.00207	0.00489	CbGeAlD
Levonorgestrel—SHBG—brain—germ cell cancer	0.00206	0.00487	CbGeAlD
Levonorgestrel—AR—head—germ cell cancer	0.00204	0.00482	CbGeAlD
Levonorgestrel—ESR1—endocrine gland—germ cell cancer	0.00203	0.0048	CbGeAlD
Levonorgestrel—ESR1—head—germ cell cancer	0.00201	0.00474	CbGeAlD
Levonorgestrel—AR—testis—germ cell cancer	0.00197	0.00466	CbGeAlD
Levonorgestrel—ESR1—testis—germ cell cancer	0.00194	0.00458	CbGeAlD
Levonorgestrel—PGR—brain—germ cell cancer	0.00186	0.00439	CbGeAlD
Levonorgestrel—PGR—lymph node—germ cell cancer	0.0018	0.00424	CbGeAlD
Levonorgestrel—ESR1—cerebellum—germ cell cancer	0.00179	0.00423	CbGeAlD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.00178	0.0132	CbGpPWpGaD
Levonorgestrel—CYP19A1—brain—germ cell cancer	0.00167	0.00395	CbGeAlD
Levonorgestrel—CYP19A1—lymph node—germ cell cancer	0.00162	0.00382	CbGeAlD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.00155	0.0114	CbGpPWpGaD
Levonorgestrel—Erythema multiforme—Ifosfamide—germ cell cancer	0.00153	0.00351	CcSEcCtD
Levonorgestrel—Anaemia—Bleomycin—germ cell cancer	0.00153	0.0035	CcSEcCtD
Levonorgestrel—Anorexia—Vinblastine—germ cell cancer	0.00152	0.00349	CcSEcCtD
Levonorgestrel—Eye disorder—Ifosfamide—germ cell cancer	0.00152	0.00347	CcSEcCtD
Levonorgestrel—Cardiac disorder—Ifosfamide—germ cell cancer	0.00151	0.00345	CcSEcCtD
Levonorgestrel—Cystitis noninfective—Methotrexate—germ cell cancer	0.00149	0.00342	CcSEcCtD
Levonorgestrel—AR—brain—germ cell cancer	0.00148	0.0035	CbGeAlD
Levonorgestrel—PGR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00148	0.0109	CbGpPWpGaD
Levonorgestrel—Cystitis—Methotrexate—germ cell cancer	0.00148	0.00338	CcSEcCtD
Levonorgestrel—Immune system disorder—Ifosfamide—germ cell cancer	0.00147	0.00336	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00146	0.00335	CcSEcCtD
Levonorgestrel—ESR1—brain—germ cell cancer	0.00145	0.00343	CbGeAlD
Levonorgestrel—Arrhythmia—Ifosfamide—germ cell cancer	0.00145	0.00332	CcSEcCtD
Levonorgestrel—Vaginal infection—Methotrexate—germ cell cancer	0.00144	0.00331	CcSEcCtD
Levonorgestrel—Cough—Bleomycin—germ cell cancer	0.00144	0.0033	CcSEcCtD
Levonorgestrel—Pneumonia—Etoposide—germ cell cancer	0.00144	0.00329	CcSEcCtD
Levonorgestrel—Alopecia—Ifosfamide—germ cell cancer	0.00143	0.00328	CcSEcCtD
Levonorgestrel—AR—lymph node—germ cell cancer	0.00143	0.00338	CbGeAlD
Levonorgestrel—Infestation NOS—Etoposide—germ cell cancer	0.00143	0.00327	CcSEcCtD
Levonorgestrel—Infestation—Etoposide—germ cell cancer	0.00143	0.00327	CcSEcCtD
Levonorgestrel—Anaemia—Dactinomycin—germ cell cancer	0.00142	0.00326	CcSEcCtD
Levonorgestrel—Mental disorder—Ifosfamide—germ cell cancer	0.00142	0.00326	CcSEcCtD
Levonorgestrel—Malnutrition—Ifosfamide—germ cell cancer	0.00141	0.00324	CcSEcCtD
Levonorgestrel—Erythema—Ifosfamide—germ cell cancer	0.00141	0.00324	CcSEcCtD
Levonorgestrel—Chest pain—Bleomycin—germ cell cancer	0.00141	0.00322	CcSEcCtD
Levonorgestrel—Myalgia—Bleomycin—germ cell cancer	0.00141	0.00322	CcSEcCtD
Levonorgestrel—ESR1—lymph node—germ cell cancer	0.0014	0.00332	CbGeAlD
Levonorgestrel—Discomfort—Bleomycin—germ cell cancer	0.00139	0.00318	CcSEcCtD
Levonorgestrel—Decreased appetite—Vinblastine—germ cell cancer	0.00139	0.00318	CcSEcCtD
Levonorgestrel—Neoplasm—Methotrexate—germ cell cancer	0.00138	0.00317	CcSEcCtD
Levonorgestrel—Bladder pain—Methotrexate—germ cell cancer	0.00138	0.00317	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Cisplatin—germ cell cancer	0.00138	0.00316	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Cisplatin—germ cell cancer	0.00137	0.00315	CcSEcCtD
Levonorgestrel—Urethral disorder—Cisplatin—germ cell cancer	0.00137	0.00314	CcSEcCtD
Levonorgestrel—Pain—Vinblastine—germ cell cancer	0.00137	0.00313	CcSEcCtD
Levonorgestrel—Constipation—Vinblastine—germ cell cancer	0.00137	0.00313	CcSEcCtD
Levonorgestrel—Oedema—Bleomycin—germ cell cancer	0.00135	0.00309	CcSEcCtD
Levonorgestrel—Visual impairment—Cisplatin—germ cell cancer	0.00135	0.00309	CcSEcCtD
Levonorgestrel—Infection—Bleomycin—germ cell cancer	0.00134	0.00307	CcSEcCtD
Levonorgestrel—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00133	0.00983	CbGpPWpGaD
Levonorgestrel—Myalgia—Dactinomycin—germ cell cancer	0.00131	0.00301	CcSEcCtD
Levonorgestrel—Eye disorder—Cisplatin—germ cell cancer	0.00131	0.00299	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00131	0.00299	CcSEcCtD
Levonorgestrel—Anaemia—Ifosfamide—germ cell cancer	0.00131	0.00299	CcSEcCtD
Levonorgestrel—Cardiac disorder—Cisplatin—germ cell cancer	0.0013	0.00297	CcSEcCtD
Levonorgestrel—Discomfort—Dactinomycin—germ cell cancer	0.0013	0.00297	CcSEcCtD
Levonorgestrel—Angioedema—Ifosfamide—germ cell cancer	0.00129	0.00296	CcSEcCtD
Levonorgestrel—Anorexia—Bleomycin—germ cell cancer	0.00129	0.00295	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Etoposide—germ cell cancer	0.00127	0.00292	CcSEcCtD
Levonorgestrel—Vertigo—Ifosfamide—germ cell cancer	0.00127	0.00291	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Etoposide—germ cell cancer	0.00127	0.0029	CcSEcCtD
Levonorgestrel—Immune system disorder—Cisplatin—germ cell cancer	0.00126	0.00289	CcSEcCtD
Levonorgestrel—Abdominal pain—Vinblastine—germ cell cancer	0.00126	0.00289	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Cisplatin—germ cell cancer	0.00126	0.00289	CcSEcCtD
Levonorgestrel—Oedema—Dactinomycin—germ cell cancer	0.00126	0.00288	CcSEcCtD
Levonorgestrel—Urethral disorder—Etoposide—germ cell cancer	0.00126	0.00288	CcSEcCtD
Levonorgestrel—Infection—Dactinomycin—germ cell cancer	0.00125	0.00286	CcSEcCtD
Levonorgestrel—Arrhythmia—Cisplatin—germ cell cancer	0.00125	0.00286	CcSEcCtD
Levonorgestrel—Palpitations—Ifosfamide—germ cell cancer	0.00125	0.00286	CcSEcCtD
Levonorgestrel—Alopecia—Cisplatin—germ cell cancer	0.00124	0.00283	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00124	0.00912	CbGpPWpGaD
Levonorgestrel—Cough—Ifosfamide—germ cell cancer	0.00123	0.00282	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00123	0.00282	CcSEcCtD
Levonorgestrel—Hypertension—Ifosfamide—germ cell cancer	0.00122	0.00279	CcSEcCtD
Levonorgestrel—Erythema—Cisplatin—germ cell cancer	0.00122	0.00279	CcSEcCtD
Levonorgestrel—Malnutrition—Cisplatin—germ cell cancer	0.00122	0.00279	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—FGF4—germ cell cancer	0.00122	0.00897	CbGpPWpGaD
Levonorgestrel—Erythema multiforme—Etoposide—germ cell cancer	0.00121	0.00278	CcSEcCtD
Levonorgestrel—Dyspnoea—Bleomycin—germ cell cancer	0.0012	0.00275	CcSEcCtD
Levonorgestrel—Myalgia—Ifosfamide—germ cell cancer	0.0012	0.00275	CcSEcCtD
Levonorgestrel—Chest pain—Ifosfamide—germ cell cancer	0.0012	0.00275	CcSEcCtD
Levonorgestrel—Flatulence—Cisplatin—germ cell cancer	0.0012	0.00275	CcSEcCtD
Levonorgestrel—Anorexia—Dactinomycin—germ cell cancer	0.0012	0.00275	CcSEcCtD
Levonorgestrel—Eye disorder—Etoposide—germ cell cancer	0.0012	0.00274	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00119	0.00274	CcSEcCtD
Levonorgestrel—Cardiac disorder—Etoposide—germ cell cancer	0.00119	0.00272	CcSEcCtD
Levonorgestrel—Discomfort—Ifosfamide—germ cell cancer	0.00119	0.00272	CcSEcCtD
Levonorgestrel—Hypersensitivity—Vinblastine—germ cell cancer	0.00118	0.0027	CcSEcCtD
Levonorgestrel—Decreased appetite—Bleomycin—germ cell cancer	0.00117	0.00269	CcSEcCtD
Levonorgestrel—Muscle spasms—Cisplatin—germ cell cancer	0.00117	0.00268	CcSEcCtD
Levonorgestrel—Immune system disorder—Etoposide—germ cell cancer	0.00116	0.00265	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Etoposide—germ cell cancer	0.00115	0.00265	CcSEcCtD
Levonorgestrel—Pain—Bleomycin—germ cell cancer	0.00115	0.00264	CcSEcCtD
Levonorgestrel—Oedema—Ifosfamide—germ cell cancer	0.00115	0.00264	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00115	0.00263	CcSEcCtD
Levonorgestrel—Asthenia—Vinblastine—germ cell cancer	0.00115	0.00262	CcSEcCtD
Levonorgestrel—Infection—Ifosfamide—germ cell cancer	0.00115	0.00262	CcSEcCtD
Levonorgestrel—CYP3A4—endocrine gland—germ cell cancer	0.00113	0.00268	CbGeAlD
Levonorgestrel—Alopecia—Etoposide—germ cell cancer	0.00113	0.00259	CcSEcCtD
Levonorgestrel—Nervous system disorder—Ifosfamide—germ cell cancer	0.00113	0.00259	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00113	0.00833	CbGpPWpGaD
Levonorgestrel—Anaemia—Cisplatin—germ cell cancer	0.00113	0.00258	CcSEcCtD
Levonorgestrel—Skin disorder—Ifosfamide—germ cell cancer	0.00112	0.00257	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00111	0.00255	CcSEcCtD
Levonorgestrel—Anorexia—Ifosfamide—germ cell cancer	0.0011	0.00252	CcSEcCtD
Levonorgestrel—Decreased appetite—Dactinomycin—germ cell cancer	0.00109	0.00251	CcSEcCtD
Levonorgestrel—Diarrhoea—Vinblastine—germ cell cancer	0.00109	0.0025	CcSEcCtD
Levonorgestrel—Fatigue—Dactinomycin—germ cell cancer	0.00108	0.00248	CcSEcCtD
Levonorgestrel—Back pain—Etoposide—germ cell cancer	0.00108	0.00247	CcSEcCtD
Levonorgestrel—Pain—Dactinomycin—germ cell cancer	0.00108	0.00246	CcSEcCtD
Levonorgestrel—Muscle spasms—Etoposide—germ cell cancer	0.00107	0.00246	CcSEcCtD
Levonorgestrel—Urticaria—Bleomycin—germ cell cancer	0.00107	0.00245	CcSEcCtD
Levonorgestrel—Body temperature increased—Bleomycin—germ cell cancer	0.00107	0.00244	CcSEcCtD
Levonorgestrel—Dizziness—Vinblastine—germ cell cancer	0.00106	0.00242	CcSEcCtD
Levonorgestrel—Mood swings—Methotrexate—germ cell cancer	0.00105	0.00241	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00105	0.00241	CcSEcCtD
Levonorgestrel—Myalgia—Cisplatin—germ cell cancer	0.00104	0.00237	CcSEcCtD
Levonorgestrel—Anxiety—Cisplatin—germ cell cancer	0.00103	0.00237	CcSEcCtD
Levonorgestrel—Anaemia—Etoposide—germ cell cancer	0.00103	0.00236	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00103	0.00236	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00103	0.00236	CcSEcCtD
Levonorgestrel—Dyspnoea—Ifosfamide—germ cell cancer	0.00103	0.00235	CcSEcCtD
Levonorgestrel—Somnolence—Ifosfamide—germ cell cancer	0.00102	0.00235	CcSEcCtD
Levonorgestrel—Discomfort—Cisplatin—germ cell cancer	0.00102	0.00235	CcSEcCtD
Levonorgestrel—Vomiting—Vinblastine—germ cell cancer	0.00102	0.00233	CcSEcCtD
Levonorgestrel—Breast disorder—Methotrexate—germ cell cancer	0.001	0.0023	CcSEcCtD
Levonorgestrel—Vertigo—Etoposide—germ cell cancer	0.001	0.0023	CcSEcCtD
Levonorgestrel—Decreased appetite—Ifosfamide—germ cell cancer	0.001	0.0023	CcSEcCtD
Levonorgestrel—Headache—Vinblastine—germ cell cancer	0.001	0.00229	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—KITLG—germ cell cancer	0.000999	0.00737	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000995	0.00228	CcSEcCtD
Levonorgestrel—Body temperature increased—Dactinomycin—germ cell cancer	0.000994	0.00228	CcSEcCtD
Levonorgestrel—Abdominal pain—Dactinomycin—germ cell cancer	0.000994	0.00228	CcSEcCtD
Levonorgestrel—Fatigue—Ifosfamide—germ cell cancer	0.000994	0.00228	CcSEcCtD
Levonorgestrel—Oedema—Cisplatin—germ cell cancer	0.000994	0.00228	CcSEcCtD
Levonorgestrel—Hypersensitivity—Bleomycin—germ cell cancer	0.000994	0.00228	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—SLC2A3—germ cell cancer	0.00099	0.00731	CbGpPWpGaD
Levonorgestrel—Infection—Cisplatin—germ cell cancer	0.000987	0.00226	CcSEcCtD
Levonorgestrel—Pain—Ifosfamide—germ cell cancer	0.000986	0.00226	CcSEcCtD
Levonorgestrel—Constipation—Ifosfamide—germ cell cancer	0.000986	0.00226	CcSEcCtD
Levonorgestrel—Loss of consciousness—Etoposide—germ cell cancer	0.00098	0.00225	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—SLC22A3—germ cell cancer	0.000975	0.0072	CbGpPWpGaD
Levonorgestrel—Nervous system disorder—Cisplatin—germ cell cancer	0.000974	0.00223	CcSEcCtD
Levonorgestrel—Cough—Etoposide—germ cell cancer	0.000973	0.00223	CcSEcCtD
Levonorgestrel—Asthenia—Bleomycin—germ cell cancer	0.000968	0.00222	CcSEcCtD
Levonorgestrel—Skin disorder—Cisplatin—germ cell cancer	0.000965	0.00221	CcSEcCtD
Levonorgestrel—Hypertension—Etoposide—germ cell cancer	0.000963	0.00221	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Cisplatin—germ cell cancer	0.000961	0.0022	CcSEcCtD
Levonorgestrel—Asthma—Methotrexate—germ cell cancer	0.000959	0.0022	CcSEcCtD
Levonorgestrel—Pruritus—Bleomycin—germ cell cancer	0.000954	0.00219	CcSEcCtD
Levonorgestrel—Chest pain—Etoposide—germ cell cancer	0.00095	0.00218	CcSEcCtD
Levonorgestrel—Nausea—Vinblastine—germ cell cancer	0.000948	0.00217	CcSEcCtD
Levonorgestrel—Anorexia—Cisplatin—germ cell cancer	0.000947	0.00217	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000943	0.00216	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000942	0.00216	CcSEcCtD
Levonorgestrel—Discomfort—Etoposide—germ cell cancer	0.000938	0.00215	CcSEcCtD
Levonorgestrel—Hypersensitivity—Dactinomycin—germ cell cancer	0.000927	0.00212	CcSEcCtD
Levonorgestrel—Urticaria—Ifosfamide—germ cell cancer	0.000916	0.0021	CcSEcCtD
Levonorgestrel—Body temperature increased—Ifosfamide—germ cell cancer	0.000911	0.00209	CcSEcCtD
Levonorgestrel—Abdominal pain—Ifosfamide—germ cell cancer	0.000911	0.00209	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000905	0.00207	CcSEcCtD
Levonorgestrel—Infection—Etoposide—germ cell cancer	0.000904	0.00207	CcSEcCtD
Levonorgestrel—Asthenia—Dactinomycin—germ cell cancer	0.000902	0.00207	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—germ cell cancer	0.000897	0.00205	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000891	0.00204	CcSEcCtD
Levonorgestrel—Dyspnoea—Cisplatin—germ cell cancer	0.000886	0.00203	CcSEcCtD
Levonorgestrel—Skin disorder—Etoposide—germ cell cancer	0.000884	0.00203	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Etoposide—germ cell cancer	0.00088	0.00202	CcSEcCtD
Levonorgestrel—ESR1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000869	0.00641	CbGpPWpGaD
Levonorgestrel—Anorexia—Etoposide—germ cell cancer	0.000868	0.00199	CcSEcCtD
Levonorgestrel—Decreased appetite—Cisplatin—germ cell cancer	0.000864	0.00198	CcSEcCtD
Levonorgestrel—Diarrhoea—Dactinomycin—germ cell cancer	0.000861	0.00197	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—germ cell cancer	0.00086	0.00197	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000858	0.00197	CcSEcCtD
Levonorgestrel—Vomiting—Bleomycin—germ cell cancer	0.000857	0.00196	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—germ cell cancer	0.000855	0.00196	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—germ cell cancer	0.000855	0.00196	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—germ cell cancer	0.000852	0.00195	CcSEcCtD
Levonorgestrel—Rash—Bleomycin—germ cell cancer	0.00085	0.00195	CcSEcCtD
Levonorgestrel—Pain—Cisplatin—germ cell cancer	0.00085	0.00195	CcSEcCtD
Levonorgestrel—Dermatitis—Bleomycin—germ cell cancer	0.00085	0.00195	CcSEcCtD
Levonorgestrel—Hypersensitivity—Ifosfamide—germ cell cancer	0.000849	0.00195	CcSEcCtD
Levonorgestrel—Asthenia—Ifosfamide—germ cell cancer	0.000827	0.00189	CcSEcCtD
Levonorgestrel—Pruritus—Ifosfamide—germ cell cancer	0.000815	0.00187	CcSEcCtD
Levonorgestrel—Dyspnoea—Etoposide—germ cell cancer	0.000812	0.00186	CcSEcCtD
Levonorgestrel—Somnolence—Etoposide—germ cell cancer	0.000809	0.00185	CcSEcCtD
Levonorgestrel—Nausea—Bleomycin—germ cell cancer	0.000801	0.00184	CcSEcCtD
Levonorgestrel—AR—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.0008	0.00591	CbGpPWpGaD
Levonorgestrel—Vomiting—Dactinomycin—germ cell cancer	0.0008	0.00183	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—CRABP1—germ cell cancer	0.000795	0.00587	CbGpPWpGaD
Levonorgestrel—Rash—Dactinomycin—germ cell cancer	0.000793	0.00182	CcSEcCtD
Levonorgestrel—Decreased appetite—Etoposide—germ cell cancer	0.000791	0.00181	CcSEcCtD
Levonorgestrel—Diarrhoea—Ifosfamide—germ cell cancer	0.000789	0.00181	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000786	0.0018	CcSEcCtD
Levonorgestrel—Body temperature increased—Cisplatin—germ cell cancer	0.000786	0.0018	CcSEcCtD
Levonorgestrel—Fatigue—Etoposide—germ cell cancer	0.000785	0.0018	CcSEcCtD
Levonorgestrel—Pain—Etoposide—germ cell cancer	0.000778	0.00178	CcSEcCtD
Levonorgestrel—Constipation—Etoposide—germ cell cancer	0.000778	0.00178	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—germ cell cancer	0.000771	0.00177	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—germ cell cancer	0.000767	0.00176	CcSEcCtD
Levonorgestrel—Dizziness—Ifosfamide—germ cell cancer	0.000762	0.00175	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—germ cell cancer	0.000762	0.00175	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—germ cell cancer	0.000758	0.00174	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—germ cell cancer	0.000752	0.00172	CcSEcCtD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.000749	0.00553	CbGpPWpGaD
Levonorgestrel—Nausea—Dactinomycin—germ cell cancer	0.000747	0.00171	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Etoposide—germ cell cancer	0.000744	0.00171	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000742	0.00548	CbGpPWpGaD
Levonorgestrel—Visual impairment—Methotrexate—germ cell cancer	0.00074	0.00169	CcSEcCtD
Levonorgestrel—Vomiting—Ifosfamide—germ cell cancer	0.000733	0.00168	CcSEcCtD
Levonorgestrel—Hypersensitivity—Cisplatin—germ cell cancer	0.000732	0.00168	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000728	0.00538	CbGpPWpGaD
Levonorgestrel—Rash—Ifosfamide—germ cell cancer	0.000727	0.00167	CcSEcCtD
Levonorgestrel—Dermatitis—Ifosfamide—germ cell cancer	0.000726	0.00166	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—germ cell cancer	0.000726	0.00166	CcSEcCtD
Levonorgestrel—Urticaria—Etoposide—germ cell cancer	0.000723	0.00166	CcSEcCtD
Levonorgestrel—Abdominal pain—Etoposide—germ cell cancer	0.00072	0.00165	CcSEcCtD
Levonorgestrel—Body temperature increased—Etoposide—germ cell cancer	0.00072	0.00165	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—germ cell cancer	0.000717	0.00164	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—FGF4—germ cell cancer	0.000713	0.00527	CbGpPWpGaD
Levonorgestrel—Asthenia—Cisplatin—germ cell cancer	0.000713	0.00163	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—NR0B1—germ cell cancer	0.000713	0.00526	CbGpPWpGaD
Levonorgestrel—Cardiac disorder—Methotrexate—germ cell cancer	0.000712	0.00163	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—germ cell cancer	0.000693	0.00159	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—germ cell cancer	0.000692	0.00158	CcSEcCtD
Levonorgestrel—Nausea—Ifosfamide—germ cell cancer	0.000685	0.00157	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—KIT—germ cell cancer	0.000681	0.00503	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Cisplatin—germ cell cancer	0.00068	0.00156	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—germ cell cancer	0.000678	0.00155	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—germ cell cancer	0.000672	0.00154	CcSEcCtD
Levonorgestrel—Hypersensitivity—Etoposide—germ cell cancer	0.000671	0.00154	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—germ cell cancer	0.000668	0.00153	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—germ cell cancer	0.000668	0.00153	CcSEcCtD
Levonorgestrel—Asthenia—Etoposide—germ cell cancer	0.000653	0.0015	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—germ cell cancer	0.000646	0.00148	CcSEcCtD
Levonorgestrel—Pruritus—Etoposide—germ cell cancer	0.000644	0.00148	CcSEcCtD
Levonorgestrel—Vomiting—Cisplatin—germ cell cancer	0.000632	0.00145	CcSEcCtD
Levonorgestrel—Rash—Cisplatin—germ cell cancer	0.000627	0.00144	CcSEcCtD
Levonorgestrel—Dermatitis—Cisplatin—germ cell cancer	0.000626	0.00143	CcSEcCtD
Levonorgestrel—Diarrhoea—Etoposide—germ cell cancer	0.000623	0.00143	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—DNMT3L—germ cell cancer	0.000618	0.00456	CbGpPWpGaD
Levonorgestrel—Anaemia—Methotrexate—germ cell cancer	0.000618	0.00141	CcSEcCtD
Levonorgestrel—ESR1—FOXM1 transcription factor network—MYC—germ cell cancer	0.000616	0.00455	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—MYC—germ cell cancer	0.000604	0.00446	CbGpPWpGaD
Levonorgestrel—Dizziness—Etoposide—germ cell cancer	0.000602	0.00138	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—germ cell cancer	0.0006	0.00138	CcSEcCtD
Levonorgestrel—Nausea—Cisplatin—germ cell cancer	0.00059	0.00135	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—KITLG—germ cell cancer	0.000586	0.00433	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000585	0.00432	CbGpPWpGaD
Levonorgestrel—Cough—Methotrexate—germ cell cancer	0.000583	0.00134	CcSEcCtD
Levonorgestrel—Vomiting—Etoposide—germ cell cancer	0.000579	0.00133	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—RARS—germ cell cancer	0.000574	0.00424	CbGpPWpGaD
Levonorgestrel—Rash—Etoposide—germ cell cancer	0.000574	0.00132	CcSEcCtD
Levonorgestrel—Dermatitis—Etoposide—germ cell cancer	0.000573	0.00131	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000573	0.00423	CbGpPWpGaD
Levonorgestrel—Headache—Etoposide—germ cell cancer	0.00057	0.00131	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—germ cell cancer	0.000569	0.0013	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—germ cell cancer	0.000569	0.0013	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000565	0.00129	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—germ cell cancer	0.000562	0.00129	CcSEcCtD
Levonorgestrel—AR—Gene Expression—NR0B1—germ cell cancer	0.000543	0.00401	CbGpPWpGaD
Levonorgestrel—Infection—Methotrexate—germ cell cancer	0.000542	0.00124	CcSEcCtD
Levonorgestrel—Nausea—Etoposide—germ cell cancer	0.000541	0.00124	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—germ cell cancer	0.000535	0.00123	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—germ cell cancer	0.00053	0.00121	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—germ cell cancer	0.000527	0.00121	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—germ cell cancer	0.00052	0.00119	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000497	0.00114	CcSEcCtD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—germ cell cancer	0.000496	0.00366	CbGpPWpGaD
Levonorgestrel—Insomnia—Methotrexate—germ cell cancer	0.000493	0.00113	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	0.000493	0.00364	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Methotrexate—germ cell cancer	0.000486	0.00111	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—germ cell cancer	0.000485	0.00111	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—germ cell cancer	0.00048	0.0011	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	0.000477	0.00352	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Methotrexate—germ cell cancer	0.000474	0.00109	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000473	0.00349	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—DNMT3L—germ cell cancer	0.000471	0.00348	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000471	0.00108	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—germ cell cancer	0.00047	0.00108	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—germ cell cancer	0.000466	0.00107	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.00045	0.00332	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000446	0.00102	CcSEcCtD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	0.00044	0.00325	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RARS—germ cell cancer	0.000438	0.00323	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—FGFR3—germ cell cancer	0.000436	0.00322	CbGpPWpGaD
Levonorgestrel—Urticaria—Methotrexate—germ cell cancer	0.000433	0.000992	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—germ cell cancer	0.000431	0.000988	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—germ cell cancer	0.000431	0.000988	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—MYC—germ cell cancer	0.000419	0.00309	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR0B1—germ cell cancer	0.000418	0.00309	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MYC—germ cell cancer	0.000409	0.00302	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Methotrexate—germ cell cancer	0.000402	0.00092	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—KIT—germ cell cancer	0.0004	0.00295	CbGpPWpGaD
Levonorgestrel—Asthenia—Methotrexate—germ cell cancer	0.000391	0.000896	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000388	0.00286	CbGpPWpGaD
Levonorgestrel—Pruritus—Methotrexate—germ cell cancer	0.000386	0.000884	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—germ cell cancer	0.000373	0.000855	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	0.000364	0.00269	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—DNMT3L—germ cell cancer	0.000363	0.00268	CbGpPWpGaD
Levonorgestrel—Dizziness—Methotrexate—germ cell cancer	0.000361	0.000826	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—germ cell cancer	0.000347	0.000794	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—germ cell cancer	0.000344	0.000788	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—germ cell cancer	0.000343	0.000787	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—germ cell cancer	0.000342	0.000783	CcSEcCtD
Levonorgestrel—ESR1—Gene Expression—RARS—germ cell cancer	0.000337	0.00249	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—germ cell cancer	0.000336	0.00248	CbGpPWpGaD
Levonorgestrel—Nausea—Methotrexate—germ cell cancer	0.000324	0.000742	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—HRAS—germ cell cancer	0.000304	0.00225	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—HRAS—germ cell cancer	0.000294	0.00217	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000287	0.00212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000247	0.00182	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000238	0.00176	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000236	0.00174	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000221	0.00163	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—H2AFZ—germ cell cancer	0.000216	0.0016	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC2A3—germ cell cancer	0.000215	0.00159	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC22A3—germ cell cancer	0.000212	0.00156	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000203	0.0015	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000195	0.00144	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—OXT—germ cell cancer	0.000184	0.00136	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000183	0.00135	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000182	0.00134	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—HRAS—germ cell cancer	0.000173	0.00128	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CRABP1—germ cell cancer	0.000173	0.00127	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—H2AFZ—germ cell cancer	0.000165	0.00122	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF4—germ cell cancer	0.000157	0.00116	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—germ cell cancer	0.000155	0.00115	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000151	0.00111	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—H2AFZ—germ cell cancer	0.000141	0.00104	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KITLG—germ cell cancer	0.000129	0.000955	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—H2AFZ—germ cell cancer	0.000127	0.000937	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AVP—germ cell cancer	0.000126	0.000933	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—germ cell cancer	0.000118	0.000873	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OXT—germ cell cancer	0.000108	0.000799	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGFR3—germ cell cancer	9.61e-05	0.00071	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF4—germ cell cancer	9.24e-05	0.000682	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—germ cell cancer	9.11e-05	0.000672	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KIT—germ cell cancer	8.83e-05	0.000652	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—H2AFZ—germ cell cancer	8.25e-05	0.000609	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KITLG—germ cell cancer	7.59e-05	0.00056	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—germ cell cancer	7.47e-05	0.000551	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AVP—germ cell cancer	7.42e-05	0.000548	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A3—germ cell cancer	6.27e-05	0.000463	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.18e-05	0.000456	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—germ cell cancer	5.69e-05	0.00042	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGFR3—germ cell cancer	5.64e-05	0.000417	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KIT—germ cell cancer	5.18e-05	0.000382	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.04e-05	0.000372	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—germ cell cancer	4.86e-05	0.000359	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—germ cell cancer	4.38e-05	0.000324	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—germ cell cancer	3.99e-05	0.000294	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—germ cell cancer	3.81e-05	0.000282	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—germ cell cancer	2.85e-05	0.00021	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—germ cell cancer	2.34e-05	0.000173	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—germ cell cancer	2.24e-05	0.000165	CbGpPWpGaD
